FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3174575855> ?p ?o ?g. }

• W3174575855 endingPage "1168" @default.
• W3174575855 startingPage "1157" @default.
• W3174575855 abstract "Prostate-specific membrane antigen (PSMA) is a promising, novel theranostic target in advanced prostate cancer (PCa). Multiple PSMA-targeted therapies are currently in clinical development, with some agents showing impressive antitumour activity, although optimal patient selection and therapeutic resistance remain ongoing challenges.To review the biology of PSMA and recent advances in PSMA-targeted therapies in PCa, and to discuss potential strategies for patient selection and further therapeutic development.A comprehensive literature search was performed using PubMed and review of American Society of Clinical Oncology and European Society of Medical Oncology annual meeting abstracts up to April 2021.PSMA is a largely extracellular protein that is frequently, but heterogeneously, expressed by PCa cells. PSMA expression is associated with disease progression, worse clinical outcomes and the presence of tumour defects in DNA damage repair (DDR). PSMA is also expressed by other cancer cell types and is implicated in glutamate and folate metabolism. It may confer a tumour survival advantage in conditions of cellular stress. PSMA regulation is complex, and recent studies have shed light on interactions with androgen receptor, PI3K/Akt, and DDR signalling. A phase 2 clinical trial has shown that 177Lu-PSMA-617 causes tumour shrinkage and delays disease progression in a significant subset of patients with metastatic castration-resistant PCa in comparison to second-line chemotherapy. Numerous novel PSMA-targeting immunotherapies, small molecules, and antibody therapies are currently in clinical development, including in earlier stages of PCa, with emerging evidence of antitumour activity. To date, the regulation and function of PSMA in PCa cells remain poorly understood.There has been rapid recent progress in PSMA-targeted therapies for the management of advanced PCa. Dissection of PSMA biology will help to identify biomarkers for and resistance mechanisms to these therapies and facilitate further therapeutic development to improve PCa patient outcomes.There have been major advances in the development of therapies targeting a molecule, PSMA, in PCa. Radioactive molecules targeting PSMA can cause tumour shrinkage and delay progression in some patients with lethal disease. Future studies are needed to determine which patients are most likely to respond, and how other treatments can be combined with therapies targeting PSMA so that more patients may benefit." @default.
• W3174575855 created "2021-07-05" @default.
• W3174575855 creator A5026608126 @default.
• W3174575855 creator A5032112072 @default.
• W3174575855 creator A5061874131 @default.
• W3174575855 creator A5064026461 @default.
• W3174575855 creator A5072378199 @default.
• W3174575855 creator A5090389551 @default.
• W3174575855 date "2022-09-01" @default.
• W3174575855 modified "2023-10-12" @default.
• W3174575855 title "Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications" @default.
• W3174575855 cites W1480741751 @default.
• W3174575855 cites W1872007843 @default.
• W3174575855 cites W1924415983 @default.
• W3174575855 cites W1965617754 @default.
• W3174575855 cites W1977316337 @default.
• W3174575855 cites W1985550922 @default.
• W3174575855 cites W1989792962 @default.
• W3174575855 cites W2000200086 @default.
• W3174575855 cites W2008088341 @default.
• W3174575855 cites W2016973566 @default.
• W3174575855 cites W2025718031 @default.
• W3174575855 cites W2026134797 @default.
• W3174575855 cites W2029345398 @default.
• W3174575855 cites W2029752064 @default.
• W3174575855 cites W2066588899 @default.
• W3174575855 cites W2074715582 @default.
• W3174575855 cites W2075417812 @default.
• W3174575855 cites W2090583090 @default.
• W3174575855 cites W2102468749 @default.
• W3174575855 cites W2105337740 @default.
• W3174575855 cites W2106497182 @default.
• W3174575855 cites W2107373757 @default.
• W3174575855 cites W2136073863 @default.
• W3174575855 cites W2137785594 @default.
• W3174575855 cites W2138743737 @default.
• W3174575855 cites W2140231263 @default.
• W3174575855 cites W2149831676 @default.
• W3174575855 cites W2151644213 @default.
• W3174575855 cites W2156913948 @default.
• W3174575855 cites W2161621282 @default.
• W3174575855 cites W2163470211 @default.
• W3174575855 cites W2168528728 @default.
• W3174575855 cites W2168755982 @default.
• W3174575855 cites W2177809753 @default.
• W3174575855 cites W2303817381 @default.
• W3174575855 cites W2466422293 @default.
• W3174575855 cites W2473278896 @default.
• W3174575855 cites W2474366905 @default.
• W3174575855 cites W2494217555 @default.
• W3174575855 cites W2522571310 @default.
• W3174575855 cites W2539038764 @default.
• W3174575855 cites W2587831721 @default.
• W3174575855 cites W2698350175 @default.
• W3174575855 cites W2740341231 @default.
• W3174575855 cites W2766204818 @default.
• W3174575855 cites W2767551096 @default.
• W3174575855 cites W2768283912 @default.
• W3174575855 cites W2769219206 @default.
• W3174575855 cites W2783667606 @default.
• W3174575855 cites W2787956080 @default.
• W3174575855 cites W2788208686 @default.
• W3174575855 cites W2790547014 @default.
• W3174575855 cites W2798177455 @default.
• W3174575855 cites W2799931007 @default.
• W3174575855 cites W2807905726 @default.
• W3174575855 cites W2809814605 @default.
• W3174575855 cites W2889646458 @default.
• W3174575855 cites W2889801464 @default.
• W3174575855 cites W2896060946 @default.
• W3174575855 cites W2898623933 @default.
• W3174575855 cites W2903299421 @default.
• W3174575855 cites W2903950335 @default.
• W3174575855 cites W2913409050 @default.
• W3174575855 cites W2931472946 @default.
• W3174575855 cites W2937040465 @default.
• W3174575855 cites W2941516488 @default.
• W3174575855 cites W2947985252 @default.
• W3174575855 cites W2963473092 @default.
• W3174575855 cites W2980243084 @default.
• W3174575855 cites W2981363847 @default.
• W3174575855 cites W2981468397 @default.
• W3174575855 cites W2982490110 @default.
• W3174575855 cites W2988034537 @default.
• W3174575855 cites W2991669855 @default.
• W3174575855 cites W2996077865 @default.
• W3174575855 cites W2999585526 @default.
• W3174575855 cites W3005893761 @default.
• W3174575855 cites W3007389375 @default.
• W3174575855 cites W3008217377 @default.
• W3174575855 cites W3023967508 @default.
• W3174575855 cites W3026141276 @default.
• W3174575855 cites W3029959649 @default.
• W3174575855 cites W3037826153 @default.
• W3174575855 cites W3041016676 @default.
• W3174575855 cites W3089634467 @default.
• W3174575855 cites W3104647211 @default.
• W3174575855 cites W3108336882 @default.

• next